Published in Br J Ophthalmol on June 01, 2001
High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes. Diabetes Care (2012) 1.55
Type 2 diabetes and cognitive impairment: linking mechanisms. J Alzheimers Dis (2012) 1.28
Advanced glycation end products: Key players in skin aging? Dermatoendocrinol (2012) 1.20
Accelerated aging in glaucoma: immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head. Invest Ophthalmol Vis Sci (2007) 1.17
Ocular fundus auto-fluorescence observations at different wavelengths in patients with age-related macular degeneration and diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol (2007) 1.14
Role of advanced glycation end products in cardiovascular disease. World J Cardiol (2012) 1.13
Dietary hyperglycemia, glycemic index and metabolic retinal diseases. Prog Retin Eye Res (2010) 1.06
Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina. Diabetologia (2007) 1.03
Mapping the nerve architecture of diabetic human corneas. Ophthalmology (2012) 1.02
Protection of retinal ganglion cells and retinal vasculature by Lycium barbarum polysaccharides in a mouse model of acute ocular hypertension. PLoS One (2012) 1.01
Improved diabetes control in the elderly delays global cognitive decline. J Nutr Health Aging (2011) 0.98
A proposed new classification for diabetic retinopathy: the concept of primary and secondary vitreopathy. Indian J Ophthalmol (2007) 0.95
Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ-related pharmacology. Br J Pharmacol (2012) 0.92
Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets. Biomed Res Int (2014) 0.89
Immunohistochemical localization of advanced glycation end products in pinguecula. Graefes Arch Clin Exp Ophthalmol (2005) 0.88
Gender difference in the association of metabolic syndrome and its components with age-related cataract: the Korea National Health and Nutrition Examination Survey 2008-2010. PLoS One (2014) 0.86
Ocular associations of metabolic syndrome. Indian J Endocrinol Metab (2012) 0.86
Two-Photon Autofluorescence Imaging Reveals Cellular Structures Throughout the Retina of the Living Primate Eye. Invest Ophthalmol Vis Sci (2016) 0.86
Green-light fundus autofluorescence in diabetic macular edema. Int J Ophthalmol (2013) 0.86
Different experimental approaches in modelling cataractogenesis: An overview of selenite-induced nuclear cataract in rats. Interdiscip Toxicol (2010) 0.85
Protein glycation inhibitory activity and antioxidant capacity of clove extract. J Food Sci Technol (2014) 0.84
Effects of age and diabetes on scleral stiffness. J Biomech Eng (2015) 0.84
Advanced glycation endproducts in human diabetic and non-diabetic cataractous lenses. Graefes Arch Clin Exp Ophthalmol (2003) 0.82
Sclera as a surrogate marker for determining AGE-modifications in Bruch's membrane using a Raman spectroscopy-based index of aging. Invest Ophthalmol Vis Sci (2011) 0.81
Association between systemic arterial stiffness and age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2006) 0.81
Advanced glycation end-products and receptor for advanced glycation end-products expression in patients with idiopathic pulmonary fibrosis and NSIP. Int J Clin Exp Pathol (2013) 0.81
Increased risk of cancer in patients with early-onset cataracts: a nationwide population-based study. Cancer Sci (2014) 0.80
Drevogenin D prevents selenite-induced oxidative stress and calpain activation in cultured rat lens. Mol Vis (2007) 0.80
Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment. Graefes Arch Clin Exp Ophthalmol (2005) 0.80
Duration of type 2 diabetes and very low density lipoprotein levels are associated with cognitive dysfunction in metabolic syndrome. Cardiovasc Psychiatry Neurol (2014) 0.78
Multifocal electroretinogram in diabetic subjects. Saudi J Ophthalmol (2012) 0.78
Advanced glycation end products and diabetic retinopathy. J Ocul Biol Dis Infor (2013) 0.77
Cardiovascular risks in prediabetes: preliminary data on "vasculopathy triad". N Am J Med Sci (2014) 0.77
The negative effects of obesity and poor glycemic control on cognitive function: a proposed model for possible mechanisms. Curr Diab Rep (2014) 0.76
Decrease in the glyceraldehyde derived advanced glycation end products in the sera of patients with Vogt-Koyanagi-Harada disease. Br J Ophthalmol (2005) 0.76
Diabetes-related adduct formation and retinopathy. J Ocul Biol Dis Infor (2011) 0.76
Changes of the thiol levels in the corneas of the diabetic rats: effect of carnosine, aspirin and a combination eye drops. Int J Ophthalmol (2010) 0.75
Featured Article: Inhibition of diabetic cataract by glucose tolerance factor extracted from yeast. Exp Biol Med (Maywood) (2016) 0.75
Effect of advanced glycation end products on oxidative stress and senescence of trabecular meshwork cells. Korean J Ophthalmol (2012) 0.75
Acetoacetate promotes the formation of fluorescent advanced glycation end products (AGEs). J Biomol Struct Dyn (2016) 0.75
Inhibitory effect of Clitoria ternatea flower petal extract on fructose-induced protein glycation and oxidation-dependent damages to albumin in vitro. BMC Complement Altern Med (2015) 0.75
Papaverine increases human serum albumin glycation. J Biol Phys (2014) 0.75
OSSC1E-K19, a novel phytochemical component of Osteomeles schwerinae, prevents glycated albumin-induced retinal vascular injury in rats. Mol Med Rep (2015) 0.75
Stress responses of human retinal pigment epithelial cells to glyoxal. Graefes Arch Clin Exp Ophthalmol (2016) 0.75
Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med (1988) 7.22
The epidemiology of open-angle glaucoma: a review. Am J Epidemiol (1983) 4.01
A prospective study of cigarette smoking and risk of cataract in men. JAMA (1992) 3.72
Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest (1994) 3.70
Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science (1986) 3.36
Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. Science (1981) 3.25
Diabetic vitreopathy. Ophthalmology (1996) 3.06
The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem J (1990) 2.83
An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature (1996) 2.71
Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J (1999) 2.61
Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem (1997) 2.53
Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci U S A (1997) 2.53
Structure of carbohydrate of hemoglobin AIc. J Biol Chem (1977) 2.21
Diabetic cataract formation: potential role of glycosylation of lens crystallins. Proc Natl Acad Sci U S A (1978) 2.14
Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci U S A (1991) 2.12
Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci U S A (1997) 2.10
Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci U S A (1992) 2.09
Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb (1994) 2.05
Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells. FASEB J (1999) 2.00
Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci U S A (1998) 1.92
Structural macromolecules and supramolecular organisation of the vitreous gel. Prog Retin Eye Res (2000) 1.91
Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest (1998) 1.85
Diabetic keratopathy. Trans Am Ophthalmol Soc (1981) 1.82
Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sci U S A (1994) 1.82
Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid. Biochem J (1991) 1.73
Alpha-crystallin as a molecular chaperone. Prog Retin Eye Res (1999) 1.68
An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. Proc Natl Acad Sci U S A (2000) 1.68
Increase in the advanced glycation end product pentosidine in Bruch's membrane with age. Invest Ophthalmol Vis Sci (1999) 1.67
End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. J Clin Invest (1990) 1.66
Drusen as risk factors in age-related macular disease. Am J Ophthalmol (1990) 1.66
Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes. J Clin Invest (1994) 1.63
Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest Ophthalmol Vis Sci (1995) 1.61
Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat. Diabetes (1991) 1.58
Modification of DNA by reducing sugars: a possible mechanism for nucleic acid aging and age-related dysfunction in gene expression. Proc Natl Acad Sci U S A (1984) 1.55
Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci U S A (1994) 1.54
Evolution of soft drusen in age-related macular degeneration. Eye (Lond) (1994) 1.54
Ageing of the human corneal stroma: structural and biochemical changes. Biochim Biophys Acta (1992) 1.52
The formation of autofluorescent granules in cultured human RPE. Invest Ophthalmol Vis Sci (1989) 1.48
Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes (1992) 1.47
Biochemical basis of lipofuscin, ceroid, and age pigment-like fluorophores. Free Radic Biol Med (1996) 1.47
Age-related changes in human vitreous structure. Graefes Arch Clin Exp Ophthalmol (1987) 1.47
The ageing lens. Ophthalmologica (2000) 1.46
Pathways of formation of glycoxidation products during glycation of collagen. Biochemistry (1995) 1.45
Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. J Biol Chem (1997) 1.44
Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. Proc Natl Acad Sci U S A (1996) 1.40
Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA study. Pathologies Oculaires Liées à l'Age. Am J Epidemiol (2000) 1.37
Alzheimer's disease--synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. J Neural Transm (Vienna) (1998) 1.35
Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am J Pathol (1997) 1.35
Pathogenesis of drusen in the primate. Invest Ophthalmol Vis Sci (1986) 1.33
Glycation of skin collagen in type I diabetes mellitus. Correlation with long-term complications. Diabetes (1986) 1.27
Techniques for stiffening the cornea. J Refract Surg (2000) 1.26
Detection of D-glucose-derived pyrrole compounds during Maillard reaction under physiological conditions. Carbohydr Res (1987) 1.23
Epidemiology of age-related cataract. Eye (Lond) (1999) 1.22
Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline. J Clin Invest (1992) 1.21
Dietary glycotoxins: inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration. Diabetes (1999) 1.21
Differential accumulation of advanced glycation end products in the course of diabetic retinopathy. Diabetologia (1999) 1.17
The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas. Diabetologia (1997) 1.16
N(epsilon)(carboxymethyl)lysin and the AGE receptor RAGE colocalize in age-related macular degeneration. Invest Ophthalmol Vis Sci (1999) 1.16
Changes in the collagenous matrix of the aging human lamina cribrosa. Br J Ophthalmol (1995) 1.16
Increased serum levels of advanced glycation end-products and diabetic complications. Diabetes Res Clin Pract (1998) 1.15
Advanced glycation end products in diabetic corneas. Invest Ophthalmol Vis Sci (2000) 1.14
Analysis of microtubule-associated protein tau glycation in paired helical filaments. J Biol Chem (1994) 1.10
Role of nonenzymatic glycosylation in the development of the sequelae of diabetes mellitus. Metabolism (1979) 1.09
Advanced glycation end products in vitreous: Structural and functional implications for diabetic vitreopathy. Invest Ophthalmol Vis Sci (1998) 1.09
The relationships of age changes in retinal pigment epithelium and Bruch's membrane. Invest Ophthalmol Vis Sci (1999) 1.09
Advanced Maillard reaction and crosslinking of corneal collagen in diabetes. Biochem Biophys Res Commun (1995) 1.08
Protein crosslinking by the Maillard reaction: dicarbonyl-derived imidazolium crosslinks in aging and diabetes. Arch Biochem Biophys (1999) 1.08
Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers. Mol Med (1998) 1.07
Anti-glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice. J Diabetes Complications (1998) 1.07
AGEs induce oxidative stress and activate protein kinase C-beta(II) in neonatal mesangial cells. Am J Physiol Renal Physiol (2000) 1.07
A redox-triggered ras-effector interaction. Recruitment of phosphatidylinositol 3'-kinase to Ras by redox stress. J Biol Chem (1998) 1.06
Advanced glycation end products induce blood-retinal barrier dysfunction in normoglycemic rats. Mol Cell Biol Res Commun (2000) 1.06
Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation. Diabetes (1997) 1.05
The advanced glycation endproduct pentosidine induces the expression of PDGF-B in human retinal pigment epithelial cells. Exp Eye Res (1998) 1.05
Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy. Arch Ophthalmol (1992) 1.04
Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products. Diabetes (1998) 1.03
Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina. Lab Invest (1996) 1.02
Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology (1997) 1.01
Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs. Mol Med (1997) 1.01
Depletion of reactive advanced glycation endproducts from diabetic uremic sera using a lysozyme-linked matrix. J Clin Invest (1997) 1.01
Advanced glycosylation end products in diabetic renal and vascular disease. Am J Kidney Dis (1995) 1.01
Pentosidine: a molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia. Diabetes Metab Rev (1991) 1.00
Significance of fructose-induced protein oxidation and formation of advanced glycation end product. J Diabetes Complications (1995) 0.99
Transition metal-catalyzed oxidation of ascorbate in human cataract extracts: possible role of advanced glycation end products. Invest Ophthalmol Vis Sci (2000) 0.97
Lysosomal enzyme cytochemistry of human RPE, Bruch's membrane and drusen. Invest Ophthalmol Vis Sci (1987) 0.97
Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Muller cells. Biochem Biophys Res Commun (1997) 0.95
Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivo. Biochem Biophys Res Commun (1996) 0.95
Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells. Biochem Biophys Res Commun (1999) 0.95
Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells. Biochem J (1999) 0.94
Regional variation and age-related changes of lysosomal enzymes in the human retinal pigment epithelium. Br J Ophthalmol (1994) 0.94
Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes (1999) 0.93
Advanced glycation endproducts accelerate calcification in microvascular pericytes. Biochem Biophys Res Commun (1999) 0.93
Human ocular drusen possess novel core domains with a distinct carbohydrate composition. J Histochem Cytochem (1999) 0.93
Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy. Diabetologia (1997) 0.93
Atherogenesis and advanced glycation: promotion, progression, and prevention. Ann N Y Acad Sci (1997) 0.93
Correlation between autofluorescent debris accumulation and the presence of partially processed forms of cathepsin D in cultured retinal pigment epithelial cells challenged with rod outer segments. Exp Eye Res (1996) 0.92
Modification of enzymatic antioxidants in retinal microvascular cells by glucose or advanced glycation end products. Free Radic Biol Med (1998) 0.92
Maillard reactions in lens proteins: methylglyoxal-mediated modifications in the rat lens. Exp Eye Res (2000) 0.91
Cellular contraction of collagen lattices is inhibited by nonenzymatic glycation. Exp Cell Res (1996) 0.90